Associations of Chronic Kidney Disease in a Cohort of Stable First-degree Relatives of Chronic Kidney Disease Patients at a Tertiary Health Facility in South Eastern Nigeria
Published: 2024-02-09
Page: 69-77
Issue: 2024 - Volume 7 [Issue 1]
Bartholomew C. Ozuemba
Department of Internal Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Anambra State, Nigeria.
Chidiebele M. Ezeude *
Department of Internal Medicine, Faculty of Medicine, Nnamdi Azikiwe University, Awka, Anambra State, Nigeria.
*Author to whom correspondence should be addressed.
Abstract
Background: First degree relatives (FDRs) of chronic kidney disease (CKD) patients have a greater prevalence of the risk factors for CKD than the general population and should be screened for kidney disease. There is paucity of data on the occurrence of CKD and its risk factors in the stable FDRs of CKD patients. This study was aimed at determining the associations between the various risk factors for CKD and hitherto undiagnosed CKD among the FDRs of the CKD patients.
Methodology: This was an observational prospective study involving 150 FDRs of CKD patients carried out in Nnewi, South-eastern Nigeria. Simple sampling technique was used to select the CKD probands while a stratified sampling technique was used to enroll the FDRs of the CKD subjects.
The subjects were screened for CKD using urine albumin creatinine ratio (uACR) and estimated glomerular filtration rate (eGFR). These were repeated after three months for the FDRs with initial abnormal results (uACR ≥ 30mg/g and/or eGFR < 60ml/min/1.73m2) based on the definition of CKD. Also, the risk factors for CKD that included hypertension, diabetes mellitus (DM), obesity, age, gender, cigarette smoking, heavy alcohol consumption, hyperuricaemia, herbal medication use and dyslipidaemia were assessed.
Results: Age, gender, hypertension, cigarette smoking, heavy alcohol consumption, dyslipidaemia, hypercholestrolaemia and hyperuricaemia were found to have significant association with the occurrence of CKD in the FDRs of CKD patients (P ˂ 0.001; P < 0.038; P ˂ 0.001; P = 0.008; P ˂ 0.001; P ˂ 0.01 & P ˂ 0.001 respectively).
There was no significant association between CKD and DM and herbal medication use (P = 0.782 & P = 0.081 respectively).
Logistic regression analysis showed that age (P = 0.009, OR 1.079, 95% C.I = 1.019 – 1.141), hypertension (P = 0.004, OR 10.602, 95% C.I = 2.085 – 53.920), and heavy alcohol consumption (P = 0.003, OR 12.657, 95% C.I = 2.316 – 69.159) were independent predictors for CKD among the FDRs.
Conclusion: Age, gender, hypertension, significant cigarette smoking, heavy alcohol consumption, dyslipidaemia, hypercholaestrolaemia and hyperuricaemia were significantly associated with the prevalence of CKD in FDRs of CKD patients while age, hypertension and heavy alcohol consumption were independent predictors of CKD in this group of subjects.
Keywords: Associations, chronic kidney disease, first degree relatives, stable
How to Cite
Downloads
References
Definition and classification of CKD. Kidney Int Suppl (2011). 2013;3(1):19–62. Accessed on: 2012 Dec 28. DOI: 10.1038/kisup.2012.64
Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022;12(1):7-11. DOI: 10.1016/j.kisu.2021.11.003.
Epub 2022 Mar 18. PMID: 35529086; PMCID: PMC9073222.
Vivekanand P, Dm J, Garcia-garcia PG, Iseki PK, Li Z, Naicker PS, et al. Chronic kidney disease : Global dimension and perspectives. Lancet. 2013;382(9888): 260–72.
Kazancioǧlu R. Risk factors for chronic kidney disease: An update. Kidney Int Suppl. 2013;3(4):368–71.
Satko SG, Sedor JR, Iyengar SK, Freedman BI. Familial clustering of chronic kidney disease. Semin Dial. 2007;20(3): 229–36.
Temgoua MN, Ashuntantang G, Essi MJ, Tochie JN, Oumarou M, Abongwa AF, et al. Prevalence and Risk Factors for Chronic Kidney Disease in Family Relatives of a Cameroonian Population of Hemodialysis Patients: A CrossSectional Study. Hosp Pract Res. 2019;4(1):12–7.
Schaeffner ES, Kurth T, De Jong PE, Glynn RJ, Buring JE, Gaziano JM. Alcohol consumption and the risk of renal dysfunction in apparently healthy men. Arch Intern Med. 2005;165(9):1048–53.
Bowe B, Xie Y, Xian H, Balasubramanian S, Al-Aly Z. Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression. Kidney Int. 2016;89(4):886–96.
Rhee CM, Ahmadi SF, Kalantar-Zadeh K. The dual roles of obesity in chronic kidney disease: A review of the current literature. Curr Opin Nephrol Hypertens. 2016;25(3): 208–16.
Bagchi S, Agarwal SK, Gupta S. Targeted screening of adult first-degree relatives for chronic kidney disease and its risk factors. Nephron - Clin Pract. 2010;116(2):128-136.
Wei X, Li Z, Chen W, Mao H, Li Z, Dong X, et al. Prevalence and risk factors of chronic kidney disease in first-degree relatives of chronic kidney disease patients in Southern China. Nephrology. 2012;17(2): 123–30.
Eleftheriadis T, Golphinopoulos S, Pissas G, Stefanidis I. Asymptomatic hyperuricemia and chronic kidney disease : Narrative review of a treatment controversial. J Adv Res. 2017;8(5):555–60.
Hallan SI, Orth SR. Smoking is a risk factor in the progression to kidney failure. Kidney Int. 2011;516–23.
Slot C. Plasma creatinine determination a new and specific jaffe reaction method. Scand J Clin Lab Invest. 1965;17(4):381–7.
Kageyama N. A direct colorimetric determination of uric acid in serum and urine with uricase - catalase system. Clinica chimica acta.1956;178 (4546):1325
Trinder P. Determination of Glucose in Blood using Glucose Oxidase with an alternative oxygen acceptor. Ann Clin Biochem. 1969;6:24–7.
KDIGO 2012 Clinical practice guidelines for the evaluation and management of CKD. Kidney Int Suppl. 2013;3(1):5–14.
Levey AS, Stevens LA, Frcp C, Schmid CH, Zhang YL, Iii AFC, et al. A New Equation to Estimate Glomerular Filteration Rate.Ann Intern Med. 2009;150 (9):604–12.
Executive Summary of the Third Report of the National Cholesterol Education Program. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc. 2001;285 (19):2486–9.
Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health. 2004;4:1–9.
World Health Organization. Definition, Diagnosis and Classication of Diabetes Mellitus and its complications. WHO, Geneva, Switzerland; 1999.
Afolabi MO, Abioye-Kuteyi EA, Arogundade FA, Bello IS. Prevalence of chronic kidney disease in a Nigerian family practice population. South African Fam Pract. 2009;51(2):132–7.
Koning SH, Gansevoort RT, Mukamal KJ, Rimm EB, Bakker SJL, Joosten MM. Alcohol consumption is inversely associated with the risk of developing chronic kidney disease. Kidney Int. 2015;87(5):1009–16.
Agaba EI, Agaba PA, Wigwe CM. Use and abuse of analgesics in Nigeria: a community survey. Nigerian Journal of Medicine. 2004;13:379–82.
Nishida C, Ko G, Kumanyika S. Body fat distribution and non communicable diseases in populations: Overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist - Hip Ratio. European Journal of Clinical Nutrition. 2009:139.
WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Heal Organ - Tech Rep Ser. 2000;894.
Chobanian A V, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. J Am Med Assoc. 2003;289(19): 2560–72.
Wattendorf DJ, Hadley DW. Family History: The Three-Generation Pedigree. American Family Physician. 2005;72(3): 441-448
Shankar A, Klein R, Klein BEK. Original Contribution The Association among Smoking , Heavy Drinking , and Chronic Kidney Disease. Am J Epidemiol. 2006;164(3):263–71.
Sertsu A, Worku T, Fekadu G, Tura AK. Prevalence of chronic kidney disease and associated factors among patients visiting St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia: A cross sectional study design. SAGE Open Medicine. 2022;10.
DOI: 10.1177/20503121221116942
Li PKT, Ng JK, Cheng YL, Kwan TH, Leung CB, Lau M et al. Relatives in silent kidney disease screening (RISKS) Study: A Chinese cohort study. Nephrology. 2017;22(54):35–42.
Egbi OG, Ahmed SD. Prevalence of Traditional Risk Factors of chronic kidney disease in An Agrarian Community in Edo State, Nigeria: Report of a Health Survey Survey. Tropical Journal of Nephrology. 2020; 15 (1): 33 – 42.
Tsai JC, Chen SC, Hwang SJ, Chang JM, Lin MY, Chen HC. Prevalence and risk factors of CKD in spouses and relatives of Hemodialysis Patients. Am J Kidney Dis. 2010;55(5):856–66.
DOI:10.1053/j.ajkd.2009.12.021.
Okwuonu CG, Chukwunonye IJ, Adejumo OA, Agaba EI, Ojogwu LI. Prevalence of Chronic Kidney Diseaase and its Risk Factors among Adults in a Semi-urban Community of South-Eastern Nigeria. Niger Post grad Med J. 2017;24:81–7.
Aljabri K. Serum lipid profiles in patients with chronic kidney disease in a Saudi population. Endocrinol Int J. 2019;7(1): 41–6.
Li L, Yang C, Zhao Y, Zeng X, Liu F, Fu P. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies. BMC Nephrol. 2014;15: 122.
Bagchi S, Agarwal SK, Gupta S. Targeted screening of adult first degree relatives for chronic kidney disease and its risk factors. Nephron Clinical Practice. 2010;116(2): c128–136. Doi.org//0.1159/000314662.